{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/47450"},"canonical_url":"https://search.dev.ndltd.org/etd/bu/oai:open.bu.edu:2144/47450","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Novel therapeutics in the treatment of drug-resistant tuberculosis: a review","abstract":"Mycobacterium tuberculosis is the causative agent of Tuberculosis infection (TB). TB is still endemic throughout the World and is a significant cause of morbidity and mortality, killing over 4,000 people every day. Although a number of antibiotics have been available for the treatment of TB since the late 1940s, treatment duration, drug-resistance, and barriers to effective health delivery have thwarted efforts for elimination (and eventually, eradication). Here is a compendium of several novel therapies that are being considered to address this global pandemic.","abstract_html":"Mycobacterium tuberculosis is the causative agent of Tuberculosis infection (TB). TB is still endemic throughout the World and is a significant cause of morbidity and mortality, killing over 4,000 people every day. Although a number of antibiotics have been available for the treatment of TB since the late 1940s, treatment duration, drug-resistance, and barriers to effective health delivery have thwarted efforts for elimination (and eventually, eradication). Here is a compendium of several novel therapies that are being considered to address this global pandemic.","abstract_has_math":false,"creators":["Kearney, John Edward"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["McKnight, C. James"],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023","date_published":"2023","updated_at":"2026-07-24T01:26:09Z","subjects":["Medicine"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/47450","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["McKnight, C. James"]},{"key":"dc:creator","label":"Author","values":["Kearney, John Edward"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2023-11-07T15:08:13Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2023-11-07T15:08:13Z"]},{"key":"dc:date.issued","label":"Date","values":["2023"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/47450"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Mycobacterium tuberculosis is the causative agent of Tuberculosis infection (TB). TB is still endemic throughout the World and is a significant cause of morbidity and mortality, killing over 4,000 people every day. Although a number of antibiotics have been available for the treatment of TB since the late 1940s, treatment duration, drug-resistance, and barriers to effective health delivery have thwarted efforts for elimination (and eventually, eradication). Here is a compendium of several novel therapies that are being considered to address this global pandemic."]},{"key":"dc:title","label":"Title","values":["Novel therapeutics in the treatment of drug-resistant tuberculosis: a review"]}]}],"canonical_facts":{"dc:contributor.advisor":["McKnight, C. James"],"dc:creator":["Kearney, John Edward"],"dc:date.accessioned":["2023-11-07T15:08:13Z"],"dc:date.available":["2023-11-07T15:08:13Z"],"dc:date.issued":["2023"],"dc:description.abstract":["Mycobacterium tuberculosis is the causative agent of Tuberculosis infection (TB). TB is still endemic throughout the World and is a significant cause of morbidity and mortality, killing over 4,000 people every day. Although a number of antibiotics have been available for the treatment of TB since the late 1940s, treatment duration, drug-resistance, and barriers to effective health delivery have thwarted efforts for elimination (and eventually, eradication). Here is a compendium of several novel therapies that are being considered to address this global pandemic."],"dc:identifier.uri":["https://hdl.handle.net/2144/47450"],"dc:language.iso":["en_US"],"dc:subject":["Medicine"],"dc:title":["Novel therapeutics in the treatment of drug-resistant tuberculosis: a review"],"dc:type":["Thesis/Dissertation"]},"updated_at":"2026-07-24T01:26:09Z"}